Genome-scale analysis of aberrant DNA methylation in colorectal cancer

Genome Research

Volumn 22, Issue 2, 2012, Pages 271-282

  Hinoue, Toshinori ^a   Weisenberger, Daniel J ^a   Lange, Christopher P E ^b,c   Shen, Hui ^a   Byun, Hyang Min ^d   Van Den Berg, David ^a   Malik, Simeen ^a   Pan, Fei ^a   Noushmehr, Houtan ^a   Van Dijk, Cornelis M ^b   Tollenaar, Rob A E M ^c   Laird, Peter W ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b GROENE HART HOSPITAL   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAF GENE; CLINICAL FEATURE; CLUSTER ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DESCENDING COLON; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE SILENCING; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MLH1 GENE; ONCOGENE; ONCOGENE K RAS; PRIORITY JOURNAL; PROMOTER REGION; TP53 GENE; TRANSCRIPTION REGULATION;

CLUSTER ANALYSIS; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MUTATION; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84856549042     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.117523.110     Document Type: Article

References (53)

1. Barbosa-Morais NL, Dunning MJ, Samarajiwa SA, Darot JF, Ritchie ME, Lynch AG, Tavare S. 2010. A re-annotation pipeline for Illumina BeadArrays: improving the interpretation of gene expression data. Nucleic Acids Res 38: e17. doi: 10.1093/nar/gkp942.
2. Baylin SB, Ohm JE. 2006. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6: 107-116. (Pubitemid 43361543)
3. Bernstein BE, Meissner A, Lander ES. 2007. The mammalian epigenome. Cell 128: 669-681. (Pubitemid 46273573)
4. Bibikova M. 2009. Genome-wide DNA methylation profiling using Infinium assay. Epigenomics 1: 177-200.
5. Campan M, Weisenberger DJ, Trinh B, Laird PW. 2009. MethyLight. Methods Mol Biol 507: 325-337.
6. Chan AO, Broaddus RR, Houlihan PS, Issa JP, Hamilton SR, Rashid A. 2002. CpG island methylation in aberrant crypt foci of the colorectum. Am J Pathol 160: 1823-1830. (Pubitemid 34525661)
7. Chan TA, Glockner S, Yi JM, Chen W, Van Neste L, Cope L, Herman JG, Velculescu V, Schuebel KE, Ahuja N, et al. 2008. Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis. PLoS Med 5: e114. doi: 10.1371/journal.pmed.0050114.
8. Cheng YW, Pincas H, Bacolod MD, Schemmann G, Giardina SF, Huang J, Barral S, Idrees K, Khan SA, Zeng Z, et al. 2008. CpG island methylator phenotype associates with low-degree chromosomal abnormalities in colorectal cancer. Clin Cancer Res 14: 6005-6013.
9. Christensen BC, Houseman EA, Godleski JJ, Marsit CJ, Longacker JL, Roelofs CR, Karagas MR, Wrensch MR, Yeh RF, Nelson HH, et al. 2009a. Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome. Cancer Res 69: 227-234.
10. Christensen BC, Houseman EA, Marsit CJ, Zheng S, Wrensch MR, Wiemels JL, Nelson HH, Karagas MR, Padbury JF, Bueno R, et al. 2009b. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet 5: e1000602. doi: 10.1371/journal.pgen.1000602.
11. Christensen BC, Kelsey KT, Zheng S, Houseman EA, Marsit CJ, Wrensch MR, Wiemels JL, Nelson HH, Karagas MR, Kushi LH, et al. 2010. Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake. PLoS Genet 6: e1001043. doi: 10.1371/journal.pgen.1001043.
12. Christensen BC, Smith AA, Zheng S, Koestler DC, Houseman EA, Marsit CJ, Wiemels JL, Nelson HH, Karagas MR, Wrensch MR, et al. 2011. DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma. J Natl Cancer Inst 103: 143-153.
13. Dickinson RE, Dallol A, Bieche I, Krex D, Morton D, Maher ER, Latif F. 2004. Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers. Br J Cancer 91: 2071-2078. (Pubitemid 40128774)
14. Du P, Kibbe WA, Lin SM. 2008. lumi: a pipeline for processing Illumina microarray. Bioinformatics 24: 1547-1548. (Pubitemid 351911712)
15. Estecio MR, Gharibyan V, Shen L, Ibrahim AE, Doshi K, He R, Jelinek J, Yang AS, Yan PS, Huang TH, et al. 2007. LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability. PLoS ONE 2: e399. doi: 10.1371/journal.pone.0000399.
16. Estecio MR, Gallegos J, Vallot C, Castoro RJ, Chung W, Maegawa S, Oki Y, Kondo Y, Jelinek J, Shen L, et al. 2010. Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancer. Genome Res 20: 1369-1382.
17. Feinberg AP, Vogelstein B. 1983. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301: 89-92. (Pubitemid 13154475)
18. Gal-Yam EN, Egger G, Iniguez L, Holster H, Einarsson S, Zhang X, Lin JC, Liang G, Jones PA, Tanay A. 2008. Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Proc Natl Acad Sci 105: 12979-12984.
19. Gama-Sosa MA, Slagel VA, Trewyn RW, Oxenhandler R, Kuo KC, Gehrke CW, Ehrlich M. 1983. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res 11: 6883-6894.
20. Goel A, Nagasaka T, Arnold CN, Inoue T, Hamilton C, Niedzwiecki D, Compton C, Mayer RJ, Goldberg R, Bertagnolli MM, et al. 2007. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Gastroenterology 132: 127-138. (Pubitemid 46108731)
21. V600E in colorectal cancer by DNA methylation profiling. PLoS ONE 4: e8357. doi: 10.1371/journal.pone.0008357.
22. Houseman EA, Christensen BC, Yeh RF, Marsit CJ, Karagas MR, Wrensch M, Nelson HH, Wiemels J, Zheng S, Wiencke JK, et al. 2008. Model-based clustering of DNA methylation array data: a recursive-partitioning algorithm for high-dimensional data arising as a mixture of beta distributions. BMC Bioinformatics 9: 365. doi: 10.1186/1471-2105-9-365.
23. Ibrahim AE, Arends MJ, Silva AL, Wyllie AH, Greger L, Ito Y, Vowler SL, Huang TH, Tavare S, Murrell A, et al. 2011. Sequential DNA methylation changes are associated with DNMT3B overexpression in colorectal neoplastic progression. Gut 60: 499-508.
24. Jass JR. 2007. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50: 113-130. (Pubitemid 44953403)
25. Jiang X, Tan J, Li J, Kivimae S, Yang X, Zhuang L, Lee PL, Chan MT, Stanton LW, Liu ET, et al. 2008. DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. Cancer Cell 13: 529-541. (Pubitemid 351766796)
26. Jones PA, Baylin SB. 2007. The epigenomics of cancer. Cell 128: 683-692. (Pubitemid 46273572)
27. Kondo Y, Shen L, Cheng AS, Ahmed S, Boumber Y, Charo C, Yamochi T, Urano T, Furukawa K, Kwabi-Addo B, et al. 2008. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet 40: 741-750. (Pubitemid 351748874)
28. Ku M, Koche RP, Rheinbay E, Mendenhall EM, Endoh M, Mikkelsen TS, Presser A, Nusbaum C, Xie X, Chi AS, et al. 2008. Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet 4: e1000242. doi: 10.1371/journal.pgen.1000242.
29. Leggett B, Whitehall V. 2010. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 138: 2088-2100.
30. Limsui D, Vierkant RA, Tillmans LS, Wang AH, Weisenberger DJ, Laird PW, Lynch CF, Anderson KE, French AJ, Haile RW, et al. 2010. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst 102: 1012-1022.
31. Marsit CJ, Christensen BC, Houseman EA, Karagas MR, Wrensch MR, Yeh RF, Nelson HH, Wiemels JL, Zheng S, Posner MR, et al. 2009. Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma. Carcinogenesis 30: 416-422.
32. Marsit CJ, Koestler DC, Christensen BC, Karagas MR, Houseman EA, Kelsey KT. 2011. DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer. J Clin Oncol 29: 1133-1139.
33. Miranda TB, Jones PA. 2007. DNA methylation: The nuts and bolts of repression. J Cell Physiol 213: 384-390. (Pubitemid 47509717)
34. Monti S, Tamayo P, Mesirov J, Golub T. 2003. Consensus Clustering: A resampling-based method for class discovery and visualization of gene expression microarray data. Machine Learning J 52: 91-118.
35. Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, Pan F, Pelloski CE, Sulman EP, Bhat KP, et al. 2010. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17: 510-522.
36. O'Brien MJ. 2007. Hyperplastic and serrated polyps of the colorectum. Gastroenterol Clin North Am 36: 947-968. (Pubitemid 350064454)
37. Ogino S, Kawasaki T, Kirkner GJ, Loda M, Fuchs CS. 2006. CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: Possible associations with male sex and KRAS mutations. J Mol Diagn 8: 582-588. (Pubitemid 44774157)
38. Ogino S, Kawasaki T, Kirkner GJ, Suemoto Y, Meyerhardt JA, Fuchs CS. 2007. Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer. Gut 56: 1564-1571. (Pubitemid 350033195)
39. Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, Cope L, Mohammad HP, Chen W, Daniel VC, Yu W, et al. 2007. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 39: 237-242.
40. Pino MS, Chung DC. 2010. The chromosomal instability pathway in colon cancer. Gastroenterology 138: 2059-2072.
41. Rodriguez J, Munoz M, Vives L, Frangou CG, Groudine M, Peinado MA. 2008. Bivalent domains enforce transcriptional memory of DNA methylated genes in cancer cells. Proc Natl Acad Sci 105: 19809-19814.
42. Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, Zimmerman J, Eden E, Yakhini Z, Ben-Shushan E, Reubinoff BE, et al. 2007. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 39: 232-236. (Pubitemid 46184355)
43. Shen L, Toyota M, Kondo Y, Lin E, Zhang L, Guo Y, Hernandez NS, Chen X, Ahmed S, Konishi K, et al. 2007. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci 104: 18654-18659. (Pubitemid 350210752)
44. Suzuki H, Igarashi S, Nojima M, Maruyama R, Yamamoto E, Kai M, Akashi H, Watanabe Y, Yamamoto H, Sasaki Y, et al. 2010. IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype. Carcinogenesis 31: 342-349.
45. Takai D, Jones PA. 2002. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci 99: 3740-3745. (Pubitemid 34252176)
46. Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I, Kerr D. 2009. Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 9: 489-499.
47. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, Kang GH, Widschwendter M, Weener D, Buchanan D, et al. 2006. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38: 787-793. (Pubitemid 43980599)
48. Widschwendter M, Fiegl H, Egle D, Mueller-Holzner E, Spizzo G, Marth C, Weisenberger DJ, Campan M, Young J, Jacobs I, et al. 2007. Epigenetic stem cell signature in cancer. Nat Genet 39: 157-158. (Pubitemid 46184343)
49. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, et al. 2007. The genomic landscapes of human breast and colorectal cancers. Science 318: 1108-1113. (Pubitemid 350134889)
50. Yagi K, Akagi K, Hayashi H, Nagae G, Tsuji S, Isagawa T, Midorikawa Y, Nishimura Y, Sakamoto H, Seto Y, et al. 2010. Three DNA methylation epigenotypes in human colorectal cancer. Clin Cancer Res 16: 21-33.
51. Young J, Jass JR. 2006. The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature. Cancer Epidemiol Biomarkers Prev 15: 1778-1784. (Pubitemid 44664248)
52. Young J, Biden KG, Simms LA, Huggard P, Karamatic R, Eyre HJ, Sutherland GR, Herath N, Barker M, Anderson GJ, et al. 2001. HPP1: A transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers. Proc Natl Acad Sci 98: 265-270. (Pubitemid 32095898)
53. Young J, Jenkins M, Parry S, Young B, Nancarrow D, English D, Giles G, Jass J. 2007. Serrated pathway colorectal cancer in the population: genetic consideration. Gut 56: 1453-1459. (Pubitemid 47517843)